Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients

Diabetologia

Volumn 45, Issue 1, 2002, Pages 85-96

  Sakuraba, H ^a   Mizukami, H ^a   Yagihashi, N ^a   Wada, R ^a   Hanyu, C ^a   Yagihashi, S ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Islet amyloid; Islet pathology; Morphometry; Oxidative stress; Type II diabetes

Indexed keywords

AMYLOID; CONGO RED; COPPER; PROINSULIN; SUPEROXIDE DISMUTASE; ZINC;

ADULT; AGED; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; DNA DAMAGE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PANCREAS INJURY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

AGED; AMYLOID; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INSULIN; ISLETS OF LANGERHANS; JAPAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; REFERENCE VALUES; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC;

EID: 0036163156     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s125-002-8248-z     Document Type: Article

References (64)

1. Pathogenesis of non-insulin-dependent (type II) diabetes mellitus
2. Natural history of B-cell dysfunction in NIDDM
3. Quantitative estimation of the pancreatic islet tissue in diabetic subjects
4. The pancreatic islets in diabetes
5. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus
6. Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects
7. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited
8. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: Quantitative changes in the pancreas in type 2 diabetes
9. Cellular composition of the human diabetes pancreas
10. In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243
11. Diabetes as increased risk factors in second- and third-generation Japanese Americans in Seattle, Washington
12. Current trend in prevalence of diabetes in Japan, 1964-1992
13. Emerging epidemic of type 2 diabetes in youth
14. Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes
15. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants
16. Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation
17. Glucose may induce cell death through a free radical-mediated mechanism
18. Accelerated loss of islet β cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus
19. Hyperglycemia-induced τ -cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes
20. Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: Slowly progressive IDDM- the clinical characterisitics and pathogenesis of the syndrome
21. Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus
22. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model
23. 8-Hydoxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure
24. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate
25. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid
26. Superoxide dismutase in psoriasis, squamous cell carcinoma and basal cell epithelioma: An immunohistochemical study
27. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus
28. Apoptotic cell death triggered by nitric oxide in pancreatic B-cell
29. Demonstration of insulin production and storage in insulinomas by in situ hybridization and immunocytochemistry
30. Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes
31. Pancreatic pathology in non-insulin dependent diabetes (NIDDM)
32. Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans
33. No decrease of the B cell mass in type 2 diabetic patients
34. No decrease of the β -cell mass in type 2 diabetic patients
35. The Endocrine Pancreas
36. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release
37. Correlations of in vivo β-cell function tests with β-cell mass and pancreatic insulin content in streptozotocin-administered baboons
38. Decreased insulin secretion in type 2 diabetes: A problem of cellular mass or function?
39. Human Type II diabetes. Morphological evidence for abnormal β-cell function
40. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type II (non-insulin-dependent) diabetic and non-diabetic individuals
41. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM)
42. The relation of islet amyloid to the clinical type of diabetes
43. Dynamics of β -cell mass in the growing rat pancreas. Estimation with a simple mathematical model
44. Poor capacity for proliferation of pancreatic β -cells in Otsuka-Long-Evans-Tokushima Fatty rat. A model of spontaneous NIDDM
45. Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor
46. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study
47. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
48. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications
49. Lipid peroxidation and biogenic aldehydes: From the identification of 4-hydroxynonenal to further achievements in biopathology
50. Distribution of reproducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype
51. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
52. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies
53. Oxidative damage to DNA in diabetes mellitus
54. Association between M/L55-polymorphism of paraxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects
55. Oxidative damage to mitochondrial DNA and its relationship to diabetic complications
56. Reactive oxygen species-induced molecular damage and its application in pathology
57. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus
58. Long term effects of aminoguanidine on insulin release and biosynthesis: Evidence that the formation of advanced glycosylation end products inhibit B cell function
59. DNA damage by the glycation products of glyceraldehyde 3-phosphated and lysine
60. Increased lipogenic capacity of the islet of obese rats; A role in the pathogenesis of NIDDM
61. Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: Decrease of islet mangan-superoxide dismutase
62. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: Regulation of glutathione synthesis and efflux
63. Cu/Zn-SOD in human pancreatic tissue and pancreatic juice
64. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus